Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17β-estradiol/progesterone

OBJECTIVE: To characterize the impact of TX-001HR on the relationship between vasomotor symptom (VMS) improvement and quality of life and sleep. METHODS: REPLENISH (NCT01942668) was a phase 3, randomized, double-blind, placebo-controlled, multicenter trial, which evaluated four daily doses of 17β-es...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirkin, Sebastian, Graham, Shelli, Revicki, Dennis A., Bender, Randall H., Bernick, Brian, Constantine, Ginger D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott-Raven Publishers 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553507/
https://www.ncbi.nlm.nih.gov/pubmed/30601452
http://dx.doi.org/10.1097/GME.0000000000001294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553507/
https://www.ncbi.nlm.nih.gov/pubmed/30601452
http://dx.doi.org/10.1097/GME.0000000000001294

Ejemplares similares